Intellia Therapeutics ($NTLA) Insider Trading & Smart Money Activity

Intellia Therapeutics, Inc. · Biotechnology · Latest filing Oct 2, 2026

Intellia Therapeutics, Inc. ($NTLA) has 1 insider trade, 4 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($23.17K), net -$23.17K.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

1

Net insider $ (12 mo)

-$23.17K

Congress trades (12 mo)

0

13F moves on file

4

Analyst ratings on file

2

NTLA insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 2
Q2 2026	0	0	0 / 0	2 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	1 · $23.17K	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All NTLA insider, congress, 13F and analyst activity

All Insiders 13F Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 2, 2026	Insider	Dube Michael PVP, Chief Accounting Officer	Sell (Open-market sale)	1.86K sh	$23.17K		+6.6%				—
Jun 16, 2026	Analyst	Canaccord Genuity	Reiterates to buy		PT $49		+4.8%	-18.5%			Read
Jun 15, 2026	Analyst	Citizens	Reiterates to buy		PT $30		+5.6%	-12.6%			Read
May 12, 2026	13F	ARK Investment Management	Added	+301.92K sh	$175.71M		-14.7%	-11.7%			—
May 12, 2026	13F	ARK Investment Management	Added	+301.92K sh	$243.90M		-14.7%	-11.7%			Read
Feb 17, 2026	13F	Baker Bros. Advisors	Sold out	-2.75M sh			+11.1%	+7.6%	-5.1%		—
Feb 17, 2026	13F	Baker Bros. Advisors	Sold out	-2.75M sh			+11.1%	+7.6%	-5.1%		—

1W / 1M / 6M = how NTLA moved from the trade or filing date.

Insider trading in NTLA: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Dube Michael P	VP, Chief Accounting Officer	1	-$23.17K		Oct 2, 2026

Institutions moving NTLA (13F)

• ARK Investment Management2
• Baker Bros. Advisors2

Analyst ratings on NTLA

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 16, 2026	Canaccord Genuity	Reiterates	buy	$49	+4.8%	-18.5%		Read
Jun 15, 2026	Citizens	Reiterates	buy	$30	+5.6%	-12.6%		Read

Frequently asked questions

Are NTLA insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $23.17K, a net -$23.17K.

What is the latest insider trade in NTLA?

Dube Michael P, VP, Chief Accounting Officer filed a sell (open-market sale) of 1.86K sh worth $23.17K on Oct 2, 2026.

Which institutions changed their NTLA positions?

Recent 13F filers moving the stock include ARK Investment Management and Baker Bros. Advisors.

Other biotechnology stocks

• $NVAX
• $PVLA
• $ABSI
• $TYRA
• $IMCR
• $COAG
• $INBX
• $TSHA

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.